D. Rea - Concepedia

Author

D. Rea

University of Birmingham

Also Known As

D Rea, D. REA, D. Rea, D. W. Rea, D.W Rea, D.W. Rea, Dana Rea, Daniel Rea, Rea, Dana

Publications

486

Citations

H-Index

Concepts

All Affiliations

University of Birmingham Cancer Research UK Clinical Trials Unit Leiden University Medical Center

About

D. Rea is an author at University of Birmingham specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	288
2	Health Sciences	2	2	52
3	Pathology	2	2	46
4	Biology	1	1	101
5	Obstetrics	1	1	18

D. Rea

Publications

288

Citations

H-Index

Page 1

	Year	Citations
BOLD v4: A Centralized Bioinformatics Platform for DNA-Based Biodiversity Data Sujeevan Ratnasingham, Catherine Wei, D. Susan Willis Chan, Methods in molecular biology BiologyBioinformatics DatabaseMolecular EcologyBiological DatabaseGenetics	2024	101
A phase I/II and pharmacokinetic study of irinotecan in combination with capecitabine as first-line therapy for advanced colorectal cancer D. Rea, J. W. R. Nortier, W.W. ten Bokkel Huinink, Annals of Oncology MedicinePharmacologyPharmacokinetic StudyColorectal CancerPharmacotherapy	2005	79
WARP - A multicentre prospective randomised controlled trial (RCT) of thrombosis prophylaxis with warfarin in cancer patients with central venous catheters (CVCs) Annie Young, Gulnaz Begum, Lucinda Billingham, Journal of Clinical Oncology Central Venous CathetersPharmacotherapyCancer PatientsThrombosisVenous Thrombosis	2005	34
Role of Tyrosine Kinase Inhibitors in Lung Cancer Jawaher Ansari, D. Palmer, D. Rea, Anti-Cancer Agents in Medicinal Chemistry Tyrosine ResiduesTyrosine KinaseMedicinePharmacologyReceptor Tyrosine Kinase	2009	30
Abstract S2-3: The Impact of Body Mass Index (BMI) on the Efficacy of Adjuvant Endocrine Therapy in Postmenopausal Hormone Sensitive Breast Cancer (BC) Patients; Exploratory Analysis from the TEAM Study C Seynaeve, E.T.M. Hille, Annette Hasenburg, Cancer Research Breast OncologyGynecologyWeight ManagementTeam StudyObesity	2010	18
Modified de Gramont with oxaliplatin in the first-line treatment of advanced colorectal cancer Michael Braun, F. Adab, C. R. Bradley, British Journal of Cancer OncologyChemoprevention StrategyMedicineColorectal CancerPathology	2003	16
Metastatic breast cancer response after Exemestane withdrawal: a case report Shree Bhide, D. Rea The Breast Surgical OncologyBreast OncologyMedicineBreast CancerSurgery	2003	10

Page 1